- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02489721
Major Complications Related to PICC and Midline Insertion (PICC/MIDLINE)
PICC and Midline Related Complications: A Multicenter Observational Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A PICC line is a Peripherally Inserted Central Catheter. It is long, small, flexible tube that is inserted into a peripheral vein, typically in the upper arm, and terminates in a large vein in the chest to obtain a central intravenous access. A Midline catheter is similar to a PICC, but it is shorter in length (about 25 cm) and is inserted into a large vein in the upper arm, terminating not beyond the axillary vein. Midline catheters offer a longer dwell time and better hemodilution than the short peripheral IV catheters.The use of PICC and Midline has been increasing in outpatient and inpatient settings. Factors driving this increased use include their ease of insertion due to the placement into a peripheral vein-a safer approach-with the benefit of a central tip location appropriate for any osmolarity and pH infusions, a low reported incidence of infection, a better patient comfort, a durable venous access, and an easier nursing management in outpatient setting. PICC placement under ultrasound guidance can be carried out with no iatrogenic, mechanical complications associated with central venous catheter insertion in the neck or chest (pneumothorax, hemothorax etc…). Despite their many advantages, recent data suggest that PICCs are associated with venous thromboembolism. The incidence of symptomatic thrombosis ranges from 1.9% to 8.4% and it increases to 75% considering also the asymptomatic one. The risk factors that predispose a patient to the development of a thrombotic complication are: the caliber of the device (≥5Fr), the position of the catheter tip, the insertion of the PICC in a paretic limb, a history of venous thrombosis, the residence time of the device and the presence of an oncological pathology. The second major complication due to the PICC insertion is the catheter related blood stream infection (CRBSI). The incidence of PICC-BSI in literature ranges from 2.0 per 1000 catheter days to 3.1 per 1000 catheter days. This disparity stems from the fact that there is no single definition of catheter infection. Multiple factors associated with patient and catheter care have been identified has having an increased risk of CRBSI and are amenable to preventive measures. Independent risk factors for PICC BSIs included congestive heart failure, intrabdominal perforation, Clostridium difficile infection, recent chemotherapy, presence of tracheostomy, and type of catheter (double or tri lumen). Limited data exists regard prospective observational study on deep vein thrombosis and CRBSI related to PICC and Midline insertion, including the different calibers of the device and the presence of single or multiple lumen.
The investigators designed a multicenter prospective observational study to determine the incidence of deep vein thrombosis, related/associated catheter blood stream infections and the incidence of all the minor complications due to PICC and Midline insertion.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Udine, Italy, 33100
- AOU Santa Maria della Misericordia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
• all patients aged 18-90 years (oncological, malignancy hematology, medical, surgical and critically ICU patients) in whom it was determined that PICC/Midline insertion was indicated.
Exclusion Criteria:
- renal insufficiency whose creatinine level was greater than 3.0 mg/dL or who were undergoing hemodialysis,
- preexisting bacteremia (ie, existing positive blood cultures that had not been repeated with negative results);
- preexisting venous thrombosis or known hypercoagulable states (such as protein C or S deficiency, Antithrombin deficiency, lupus anticoagulant);
- axillary lymphonodi dissection or alteration of lymphatic drainage;
- PICC and/or Midline insertion in a paretic arm;
- patients who had been previously enrolled in the trial.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of deep venous thrombosis (DVT) occurring after the PICC placement in all patients
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of infections related catheter
Time Frame: 2 years
|
2 years
|
Prevalence of other complications such as phlebitis, occlusion, malposition
Time Frame: 2 years
|
2 years
|
Reason of the catheter removal
Time Frame: 2 years
|
2 years
|
Prevalence of the same complications Midline related
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Livia Pompei, MD, AOU Santa Maria della Misericordia
- Study Director: Giorgio Della Rocca, MD, AOU Santa Maria della Misericordia
Publications and helpful links
General Publications
- Greene MT, Flanders SA, Woller SC, Bernstein SJ, Chopra V. The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities. Am J Med. 2015 Sep;128(9):986-93.e1. doi: 10.1016/j.amjmed.2015.03.028. Epub 2015 May 1.
- Chopra V, Fallouh N, McGuirk H, Salata B, Healy C, Kabaeva Z, Smith S, Meddings J, Flanders SA. Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case-control study. Thromb Res. 2015 May;135(5):829-34. doi: 10.1016/j.thromres.2015.02.012. Epub 2015 Feb 21.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PICC/MIDLINE1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Upper Extremity Deep Vein Thrombosis
-
University Medical Center GroningenCompletedSuspected Upper Extremity Deep Vein ThrombosisAustria, Netherlands, Italy, Belgium, Switzerland, Germany, United States
-
National Taiwan University HospitalUnknownUpper Extremity Deep Vein Thrombosis, SecondaryTaiwan
-
University of OklahomaPfizerCompleted
-
Azienda Ospedaliera Città della Salute e della...CompletedUpper Extremity Deep Vein Thrombosis, SecondaryItaly
-
Michael KovacsOttawa Hospital Research Institute; Jewish General HospitalRecruitingCancer Patients | Central Venous Catheter Thrombosis | Upper Extremity ThrombosisCanada
-
Ottawa Hospital Research InstituteUniversity of Alberta; Hamilton Health Sciences Corporation; Queen Elizabeth...CompletedThromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines (TRIM-Line)Cancer | Central Venous Catheter Thrombosis | Upper Extremity Deep Vein ThrombosisCanada
-
Assistance Publique - Hôpitaux de ParisUnknownBreast Cancer | Upper Extremity Deep Vein Thrombosis, SecondaryFrance
-
Sheba Medical CenterUnknownPaget Schroetter Syndrome
-
Intermountain Health Care, Inc.TerminatedDeep Vein Thrombosis | Venous Thromboembolism | Deep Venous Thrombosis | Thrombus | Upper Extremity Deep Venous ThrombosisUnited States
-
Amsterdam UMC, location VUmcCompletedCentral Venous Catheter ThrombosisNetherlands
Clinical Trials on PICC and Midline
-
Aalborg University HospitalUnknownCatheter-Related Infections | Catheter Related ComplicationDenmark
-
Hospital Universitari Vall d'Hebron Research InstituteUnknownDiabetes Mellitus, Type 2 | Diabetes Complications | Upper Extremity Deep Vein Thrombosis | Catheter-Related Infections | Catheterization, PeripheralSpain
-
Shandong Branden Med.Device Co.,LtdHainan Cancer HospitalNot yet recruitingInfections | Cancer | Phlebitis | Thrombus
-
University of PennsylvaniaCompletedPeripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered CathetersVenous ThrombosisUnited States
-
Hiroki YamaueKatsunari TakifujiUnknown
-
Universitair Ziekenhuis BrusselCompletedCancer | Malnutrition | InfectionBelgium
-
University of IowaCompletedVentriculo-Peritoneal Shunt InfectionUnited States
-
TeleflexArrow InternationalUnknownVascular Access Complication | Vascular Access Related InfectionUnited States
-
Cairo UniversityCompleted
-
Jena University HospitalCompleted